Once bound to the integrins, iRGD also binds to neuropilin-1 (NRP-1) and triggers a process known as the tumor-penetrating peptide (TPP) effect, which facilitates deep penetration of the liposomes into the tumor tissue. Here, NRP1 is linked to neoplasm.